Form 4 for AVIR Atea Pharmaceuticals, Inc.

Accepted 2024-06-21 00:00:00 ET · period of report 2024-06-20 · accession 0000950170-24-076379 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-06-21	2024-06-20	AVIR	Polsky Bruce	Dir	S - Sale	$3.49	-17.5K	65.6K	-21%	-$61.2K
DM	2024-06-21	2024-06-21	AVIR	Polsky Bruce	Dir	A - Grant	$0.00	+70.8K	41.2K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-06-20	S	D	17,544	$3.49	65,606	D	—	—	(F1) The shares were sold solely to cover taxes upon the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.53, inclusive.
2	Derivative	Restricted Stock Units	2024-06-21	A	A	29,600	$0.00	29,600	D	— · — to —	29,600 Common Stock	(F2) Restricted stock units convert into common stock on a one-for-one basis. (F3) The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
3	Derivative	Stock Option (Right to Buy)	2024-06-21	A	A	41,200	$0.00	41,200	D	$3.44 · — to 2034-06-20	41,200 Common Stock	(F4) The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.